FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly liquid composition of factor VII polypeptides. Invention claims liquid aqueous composition including (i) factor VII polypeptide, (ii) substance suitable for pH maintenance approximately within 4.0 to 8.0, (iii) substance selected out of list including calcium salt, magnesium salt or their mix, where (iii) concentration comprises at least 15 mM, and antioxidation agent.
EFFECT: enhanced stability.
33 cl, 7 ex, 1 dwg
Authors
Dates
2009-06-10—Published
2002-12-20—Filed